GC232000: β-GlcNAc-BSA Conjugate Pack Size:0.5 mg Anticoagulant / Dabigatran-13C13 / N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine-13C6

Anticoagulant / Dabigatran-13C13 / N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine-13C6

The glycopeptide is a substrate for Protein O-linked-mannose beta-1

45 / Multiple Myeloma / Panobinostat-d8 / LBH-589-d8

providing a straightforward route to conjugate the ligand onto NHS-activated molecules and surfaces

and AGE chemistry

GC232000: β-GlcNAc-BSA Conjugate Pack Size:0.5 mg Anticoagulant / Dabigatran-13C13 / N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine-13C6Avg. 72,871 Da A synthetic glycoconjugate (neoglycoprotein) of BSA where N Acetyl D glucosamine (GlcNAc) has been conjugated to BSA at multiple lysines by highly stable amide linkages via a discrete 9 atom triethylene glycol (PEG3) linker spacer system functionalized with carboxylic acid. O GlcNAc regulates protein functions at multiple levels, including enzymatic activity, transcriptional activity, subcellular localization, intermolecular